Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-01 Option Award | 2024-10-02 5:21 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 15,000 | $2.93 | 62,672 (Direct) | View |
| 2024-10-01 Tax Withholding | 2024-10-02 5:21 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 6,363 | $2.93 | 62,672 (Direct) | View |
| 2024-01-10 Tax Withholding | 2024-01-11 4:11 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 512 | $3 | 68,035 (Direct) | View |
| 2024-01-09 Tax Withholding | 2024-01-11 4:11 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 5,368 | $3.08 | 68,035 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:11 pm | 2024-01-09 2034-01-09 | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 41,000 | $0 | 68,035 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-05 4:02 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 2,908 | $2.18 | 32,915 (Direct) | View |
| 2023-01-09 Tax Withholding | 2023-01-11 4:03 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 2,147 | $3 | 44,823 (Direct) | View |
| 2023-01-10 Tax Withholding | 2023-01-11 4:03 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 512 | $3.195 | 44,823 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:03 pm | 2023-01-09 2033-01-09 | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 27,000 | $0 | 44,823 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 58,000 | $0.5 | 307,244 (Direct) | View |
| 2022-09-01 Tax Withholding | 2022-09-02 4:05 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 69,959 | $0.5 | 307,244 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:18 pm | 2022-01-10 2032-01-10 | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 97,000 | $0 | 351,703 (Direct) | View |
| 2022-01-10 Tax Withholding | 2022-01-12 4:18 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 7,694 | $0.917 | 351,703 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 4:04 pm | 2021-09-01 2031-09-01 | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 1,450,415 | $0 | 1,400,312 (Direct) | View |
| 2021-09-01 Tax Withholding | 2021-09-03 4:04 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 50,103 | $1.28 | 1,400,312 (Direct) | View |